<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Resmed Inc — News on 6ix</title>
<link>https://6ix.com/company/resmed-inc</link>
<description>Latest news and press releases for Resmed Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 08:53:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/resmed-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b8ed78dffbe2df11533d.webp</url>
<title>Resmed Inc</title>
<link>https://6ix.com/company/resmed-inc</link>
</image>
<item>
<title>Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - ResMed, Koninklijke Philips, and Carefusion</title>
<link>https://6ix.com/company/resmed-inc/news/sleep-apnea-devices-therapeutic-diagnostic-market-report-2026-2034-featuring-key-players-resmed-koninklijke-philips-and-carefusion</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/sleep-apnea-devices-therapeutic-diagnostic-market-report-2026-2034-featuring-key-players-resmed-koninklijke-philips-and-carefusion</guid>
<pubDate>Wed, 29 Apr 2026 08:53:00 GMT</pubDate>
<description>The global sleep apnea devices market is projected to expand from USD 7.95 billion in 2025 to USD 14.68 billion by 2034, growing at a CAGR of 7.05%. This growth is driven by a rising prevalence of sleep apnea, awareness of sleep disorders, obesity rates, and technological advancements in devices like CPAP, BiPAP, and oral appliances across home and clinical settings. Increasing focus on homecare health solutions and telemedicine adoption further boosts market expansion. However, challenges such</description>
</item>
<item>
<title>Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-to-report-third-quarter-fiscal-2026-earnings-on-april-30-2026-7</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-to-report-third-quarter-fiscal-2026-earnings-on-april-30-2026-7</guid>
<pubDate>Wed, 01 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday, April 30, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:https://investor.resmed.com•Date</description>
</item>
<item>
<title>Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach</title>
<link>https://6ix.com/company/resmed-inc/news/resmeds-global-sleep-survey-reveals-sleep-is-one-of-the-top-health-priorities-but-quality-rest-remains-out-of-reach</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmeds-global-sleep-survey-reveals-sleep-is-one-of-the-top-health-priorities-but-quality-rest-remains-out-of-reach</guid>
<pubDate>Tue, 03 Mar 2026 08:00:00 GMT</pubDate>
<description>Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of diet and exercise.Over half of respondents get quality sleep on only four nights a week or less.While 66% of people surveyed say they would seek medical help for ongoing sleep issues, just 23% actually do. SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD</description>
</item>
<item>
<title>Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-expands-us-operations-with-new-distribution-center-in-greenwood-indiana</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-expands-us-operations-with-new-distribution-center-in-greenwood-indiana</guid>
<pubDate>Tue, 24 Feb 2026 14:00:00 GMT</pubDate>
<description>Center to Create Local Jobs and Strengthen U.S. Healthcare Supply ResilienceSAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed’s U.S. presence and strengthen the company's distribution capacity to better serve patients and providers across North Ame</description>
</item>
<item>
<title>Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-inc-announces-results-second-210500871</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-inc-announces-results-second-210500871</guid>
<pubDate>Thu, 29 Jan 2026 21:05:00 GMT</pubDate>
<description>Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%Income from operations increased 18%; non-GAAP income from operations up 19%Diluted earnings per share of $2.68; non-GAAP diluted earnings per share of $2.81Operating cash flow of $340 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE)</description>
</item>
<item>
<title>Dr. Peter Craig Farrell, Founder of ResMed, Inc., to Receive Prestigious 2026 Horatio Alger Award</title>
<link>https://6ix.com/company/resmed-inc/news/dr-peter-craig-farrell-founder-of-resmed-inc-to-receive-prestigious-2026-horatio-alger-award</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/dr-peter-craig-farrell-founder-of-resmed-inc-to-receive-prestigious-2026-horatio-alger-award</guid>
<pubDate>Tue, 27 Jan 2026 13:00:00 GMT</pubDate>
<description>The Horatio Alger Association of Distinguished Americans, Inc., a nonprofit that honors leaders who have overcome adversity and supports young people in furthering their education, today announced that Dr. Peter Craig Farrell, Founder of ResMed, Inc., will receive the prestigious Horatio Alger Award and become a lifetime member of the organization. Farrell joins 10 other exceptional corporate, civic, and cultural leaders from across the country in the 2026 class of honorees. For the last 79 year</description>
</item>
<item>
<title>Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-report-second-quarter-fiscal-210500031</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-report-second-quarter-fiscal-210500031</guid>
<pubDate>Thu, 08 Jan 2026 21:05:00 GMT</pubDate>
<description>SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:•Location:https://investor.resmed.com•Dat</description>
</item>
<item>
<title>Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-announces-participation-44th-annual-210500088</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-announces-participation-44th-annual-210500088</guid>
<pubDate>Thu, 18 Dec 2025 21:05:00 GMT</pubDate>
<description>SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resm</description>
</item>
<item>
<title>Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-receives-fda-clearance-personalized-140000575</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-receives-fda-clearance-personalized-140000575</guid>
<pubDate>Mon, 08 Dec 2025 14:00:00 GMT</pubDate>
<description>Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapySAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed as Smart Comfort. Smart Comfort is the first FDA-cleared AI-enab</description>
</item>
<item>
<title>LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea</title>
<link>https://6ix.com/company/resmed-inc/news/livanova-appoints-lucile-blaise-as-global-head-of-commercialization-obstructive-sleep-apnea</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/livanova-appoints-lucile-blaise-as-global-head-of-commercialization-obstructive-sleep-apnea</guid>
<pubDate>Tue, 02 Dec 2025 14:00:00 GMT</pubDate>
<description>LONDON, December 02, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December 1. Blaise reports to Vladimir Makatsaria, Chief Executive Officer and is a member of the Executive Leadership Team.</description>
</item>
<item>
<title>Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-inc-announces-results-first-200500850</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-inc-announces-results-first-200500850</guid>
<pubDate>Thu, 30 Oct 2025 20:05:00 GMT</pubDate>
<description>Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0%Income from operations increased 15%; non-GAAP income from operations up 19%Diluted earnings per share of $2.37; non-GAAP diluted earnings per share of $2.55Operating cash flow of $457 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE)</description>
</item>
<item>
<title>Fractus files patent infringement complaint against ResMed in the Southern District of California</title>
<link>https://6ix.com/company/resmed-inc/news/fractus-files-patent-infringement-complaint-against-resmed-in-the-southern-district-of-california</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/fractus-files-patent-infringement-complaint-against-resmed-in-the-southern-district-of-california</guid>
<pubDate>Mon, 13 Oct 2025 08:00:00 GMT</pubDate>
<description>Fractus, a pioneer in geometry-based antenna technology and IP licensing, today announced that it has filed a patent infringement complaint (3:25-cv-02680-LL-JLB) against ResMed in the United States District Court for the Southern District of California. The complaint alleges that ResMed's sleep apnea devices and related connected therapy solutions infringe multiple Fractus patents covering miniaturized, high-performance multi-band antenna innovations.</description>
</item>
<item>
<title>Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-report-first-quarter-fiscal-200500819</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-report-first-quarter-fiscal-200500819</guid>
<pubDate>Thu, 09 Oct 2025 20:05:00 GMT</pubDate>
<description>SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:https://investor.resmed.com •Da</description>
</item>
<item>
<title>Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-announces-participation-bank-america-200500087</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-announces-participation-bank-america-200500087</guid>
<pubDate>Tue, 16 Sep 2025 20:05:00 GMT</pubDate>
<description>SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Conference 2025 on Tuesday, September 23, 2025, beginning at approximately 1:20 p.m. (British Summer Time) in London. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com</description>
</item>
<item>
<title>Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-launches-sleep-institute-elevate-201500509</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-launches-sleep-institute-elevate-201500509</guid>
<pubDate>Wed, 03 Sep 2025 20:15:00 GMT</pubDate>
<description>New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health careSAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute, a global clinical insights initiative dedicated to advancing the science and understanding of sleep health. Sleep Institute partners with clinicians, researc</description>
</item>
<item>
<title>Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds</title>
<link>https://6ix.com/company/resmed-inc/news/obstructive-sleep-apnea-expected-affect-130000217</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/obstructive-sleep-apnea-expected-affect-130000217</guid>
<pubDate>Wed, 27 Aug 2025 13:00:00 GMT</pubDate>
<description>Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized careSAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the publication of a landmark study in The Lancet Respiratory Medicine projecting a significant rise in obstructi</description>
</item>
<item>
<title>Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-strengthens-innovation-leadership-dual-130000656</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-strengthens-innovation-leadership-dual-130000656</guid>
<pubDate>Thu, 21 Aug 2025 13:00:00 GMT</pubDate>
<description>Milestones underscore Resmed’s leadership and commitment to delivering life-changing health technology that people love Resmed AirTouch N30i Red Dot Awards Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced that its AirTouch™ N30i nasal cradle mask won two prestigious Red Dot Awards: Pro</description>
</item>
<item>
<title>Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-announces-election-nicole-mowad-201500283</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-announces-election-nicole-mowad-201500283</guid>
<pubDate>Mon, 18 Aug 2025 20:15:00 GMT</pubDate>
<description>Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a focus on digital innovation SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. The company also announced that boa</description>
</item>
<item>
<title>Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-inc-announces-results-fourth-200500321</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-inc-announces-results-fourth-200500321</guid>
<pubDate>Thu, 31 Jul 2025 20:05:00 GMT</pubDate>
<description>Year-over-year revenue grows 10%, operating profit up 19%, non-GAAP operating profit up 19%Operating cash flow of $539 millionQuarterly dividend increases 13% to $0.60 per share Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2025. Fourth Quarter 2025 HighlightsAll comparisons are to the prior year</description>
</item>
<item>
<title>Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025</title>
<link>https://6ix.com/company/resmed-inc/news/resmed-report-fourth-quarter-fiscal-200500625</link>
<guid isPermaLink="true">https://6ix.com/company/resmed-inc/news/resmed-report-fourth-quarter-fiscal-200500625</guid>
<pubDate>Tue, 01 Jul 2025 20:05:00 GMT</pubDate>
<description>SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:https://investor.resmed.com •Date</description>
</item>
</channel>
</rss>